An interventional study of Mirogabalin and Pregabalin in Pain Postoperative, Osteoarthritis and Total Knee Arthroplasty, sponsored by Thammasat University Hospital. Recruiting at 1 site in Thailand. Open to participants aged 50 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-08-07.
Sponsored by Thammasat University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 69 studies in Pain, Postoperative with a site in Thailand — 5 open to participants now, 9 under way, 1 of them phase 3. Pain, Postoperative · Thailand.
Among the 69 studies in Pain, Postoperative with a site in Thailand, this one is the 31st largest by planned enrollment of the 63 interventional ones that give a count, is one of 5 that started in 2024, is one of 32 with no phase, and was the 62nd registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →5 of the 69 studies in Pain, Postoperative with a site in Thailand are open now. Recruiting first, the newest first:
Thammasat University · Sites in Thailand
Ages 50–80
Department of Medical Services Ministry of Public Health of Thailand · Sites in Thailand
Ages 55+
Thammasat University Hospital · Sites in Thailand
Ages 50–80
Thammasat University · Sites in Thailand
Ages 50–90
A study can be open while its sites in Thailand have not opened yet or have stopped. Only those recruiting at a site in Thailand →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 50 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
69 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is close to the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 80 across the 63 interventional studies, 271 across the 6 observational. Of the 47 that completed or were terminated, 2 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 69 have an industry lead sponsor. The 10 most frequent:
Thammasat University Hospital is the lead sponsor of 16 studies on the registry; 7 are open to participants now.
Thammasat University Hospital has 3 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
1 of the studies in Pain, Postoperative with a site in Thailand that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07453134Chulalongkorn UniversityTreatment Outcome and Patient-reported Outcomes in Patient Undergoing Non-surgical Root Canal Treatment With Different Irrigation Protocols | 2027-11-06 |
Add it to your calendar (.ics) → With an account.
Among the 69 studies in Pain, Postoperative with a site in Thailand, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this RCT is to compare efficacy between mirogabalin and pregabalin in pain reducing after unilateral primary total knee arthroplasty.
The main question[s] it aims to answer are:
Participants will randomized to mirogabalin or pregabalin group and will take the drug for 2 weeks after TKA. Researchers will compare to pregabalin group to see pain and functional outcomes after TKA.
After surgery is complete, you will be randomly assigned to receive painkillers Mirogabalin or Pregabalin along with other standard medications.
Surgery by Mirogabalin group: Participants received 5 mg of mirogabalin, one tablet taken twice a day, after breakfast and dinner, for 2 weeks.
In the pregabalin group: Participants received 75 mg of pregabalin, one tablet taken daily before bedtime, for 2 weeks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive 5 mg of mirogabalin, twice a day, after breakfast and dinner, for 2 weeks.
Drug: Mirogabalin
Participants will receive 75 mg of pregabalin, once a day before bedtime, for 2 weeks.
Drug: Pregabalin
Participants will receive 5 mg of mirogabalin, twice a day, after breakfast and dinner, for 2 weeks.
Participants will receive 75 mg of pregabalin, once a day before bedtime, for 2 weeks.
Pain score
Visual analog scale at rest and motion (0-100 points, 0 mean best, 100 mean worst)
Time frame: Every 6 hours after surgery for 2 days, then twice a day for 2 weeks, then once a week until 12 week after surgery.
Morphine consumption
Total morphine consumption in hospital (mg)
Time frame: 72 hours after surgery
Range of motion
Using long arm goniometer (degrees)
Time frame: 24 hour, 48 hour, 2 week, 6 week and 12 week after surgery
Knee society score
report in point (0-100, 0 mean worst, 100 mean best)
Time frame: 2 week, 6 week and 12 week after surgery
Knee injury and Osteoarthritis Outcome Score (KOOS)
report in point (0-100, 0 mean worst, 100 mean best)
Time frame: 2 week, 6 week and 12 week after surgery
Sedation score
report in point (0-100, 0 mean best, 100 mean worst)
Time frame: 24 hour, 48 hour, 2 week, 6 week and 12 week after surgery
Incidence of Somnolence and dizziness
Using scale "Mild, moderate and severe"
Time frame: everyday until 14 days then once a week until 12 weeks after surgery
Total hospital stay
Number of days the patient stays for surgery
Time frame: up to 1 week
Plan to share: No
Started Apr 2024 (actual). Primary completion is estimated for Aug 2026, 28 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 28 months is above that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Mirogabalin
Thammasat University Hospital